General Archive

Home » Ventures funding
  • Ventures funding, News releases

    LifeArc Ventures invests in Maxion Therapeutics

    Investment in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases

    Read more

  • News releases, Ventures funding

    LifeArc Ventures – strong performance in 2022 & sustained investment in innovation

    LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, provides an update on its portfolio.

    Read more

  • Surgery Hero's leadership team
    Ventures funding, News releases

    LifeArc Ventures invests in Surgery Hero, world’s first digital coaching clinic for patients

    Seed funding will be used to scale the solution through the application of machine learning

    Read more

  • Ventures funding, Articles & blogs

    AbbVie acquires LifeArc portfolio company DJS Antibodies

    AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS

    Read more

  • Eczema dermatitis on hands and feet.
    Ventures funding, News releases

    LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million

    First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its science

    Read more

  • Antibody, also known as an immunoglobulin (Ig). 3d vector.
    Ventures funding, News releases

    LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2

    LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has…

    Read more

  • Ventures funding, News releases

    LifeArc participates in Series A funding round for company developing pioneering new gene therapies for neurodegenerative diseases

    Helping to progress an innovative gene therapy platform from the bench to a stage where it is progressing closer to…

    Read more

  • Ventures funding, News releases

    LifeArc unveils new strategy and £1.3 billion spend to drive life-changing science

    Aims to transform the way diseases such as motor neurone disease are prevented, identified and treated.

    Read more

  • Ventures funding, News releases

    10 new data-driven health companies selected for KQ Labs accelerator programme

    10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised mentoring and coaching…

    Read more

  • Ventures funding, News releases

    LifeArc invests in company developing personalised drug and digital combination treatments

    LifeArc and partners announce a £13 million financing deal in Closed Loop Medicine to enable the company to develop further…

    Read more

  • LifeArc Stevenage
    Ventures funding, News releases

    Three new Trustees bring more skills and experience to LifeArc

    A very warm welcome to three new Trustees who have joined our Board.

    Read more

  • Man using Cumulus Neuroscience EEG headset
    News releases, Ventures funding

    LifeArc invests in Cumulus Neuroscience

    Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund

    Read more

WordPress development by Andy White using PorterWP